Healthcare Sector Stocks
The Healthcare sector has a total of 1062 stocks, with a combined market cap of $8.29 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 40.58.
Market Cap
8.29T
Revenue
4.52T
Profits
204.37B
PE Ratio
40.58
Profit Margin
4.52%
Dividend Yield
0.46%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 785.87B | -2.09% | 2,739,565 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 579.15B | 0.51% | 7,628,649 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 370.38B | -0.81% | 5,653,605 | 61.16B |
| 4 | MRK | Merck & Co., Inc. | 295.77B | 0.59% | 8,344,315 | 65.01B |
| 5 | AZN | AstraZeneca PLC | 294.79B | 2.74% | 2,762,776 | 58.74B |
| 6 | NVS | Novartis AG | 285.41B | -1.02% | 1,983,438 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 235.11B | -3.37% | 10,734,057 | 447.57B |
| 8 | AMGN | Amgen Inc. | 188.01B | -1.24% | 2,274,700 | 36.75B |
| 9 | ABT | Abbott Laboratories | 181.11B | -0.55% | 10,913,952 | 44.33B |
| 10 | TMO | Thermo Fisher Scientific Inc. | 175.85B | -3.17% | 1,682,901 | 44.56B |
| 11 | GILD | Gilead Sciences, Inc. | 166.63B | -1.92% | 5,663,638 | 29.44B |
| 12 | ISRG | Intuitive Surgical, Inc. | 160.77B | -3.39% | 2,107,129 | 10.06B |
| 13 | NVO | Novo Nordisk A/S | 156.42B | -0.99% | 14,690,533 | 48.59B |
| 14 | PFE | Pfizer Inc. | 153.81B | -1.92% | 29,165,055 | 62.58B |
| 15 | DHR | Danaher Corporation | 128.46B | -3.27% | 5,856,940 | 24.57B |
| 16 | SYK | Stryker Corporation | 125.31B | -1.58% | 1,786,764 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 119.52B | -1.50% | 7,908,042 | 48.19B |
| 18 | SNY | Sanofi | 114.06B | 0.34% | 3,684,691 | 54.85B |
| 19 | MDT | Medtronic plc | 111.88B | 0.21% | 10,311,422 | 35.48B |
| 20 | VRTX | Vertex Pharmaceuticals Incorporated | 110.01B | -4.56% | 1,918,938 | 12.00B |
| 21 | GSK | GSK plc | 108.87B | -0.19% | 3,034,220 | 43.97B |
| 22 | HCA | HCA Healthcare, Inc. | 105.49B | -1.76% | 801,517 | 75.60B |
| 23 | MCK | McKesson Corporation | 105.36B | -0.39% | 840,700 | 397.96B |
| 24 | BSX | Boston Scientific Corporation | 102.80B | -1.43% | 16,016,067 | 20.07B |
| 25 | CVS | CVS Health Corporation | 89.16B | -1.55% | 6,104,340 | 399.83B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 75.70B | -2.51% | 492,103 | 14.34B |
| 27 | CI | The Cigna Group | 69.07B | -3.72% | 2,262,423 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 63.21B | -2.67% | 1,352,969 | 199.13B |
| 29 | COR | Cencora, Inc. | 60.78B | -1.75% | 1,592,246 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.63B | -0.83% | 2,311,155 | 28.48B |
| 31 | MDLN | Medline Inc. | 54.33B | -2.01% | 5,274,091 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 48.61B | -0.54% | 1,306,439 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 47.85B | -2.81% | 3,797,159 | 9.47B |
| 34 | EW | Edwards Lifesciences Corporation | 45.74B | -3.36% | 4,948,380 | 6.07B |
| 35 | IDXX | IDEXX Laboratories, Inc. | 44.46B | -2.61% | 445,252 | 4.30B |
| 36 | BDX | Becton, Dickinson and Company | 44.00B | -1.82% | 2,031,774 | 21.92B |
| 37 | HLN | Haleon plc | 43.54B | 0.51% | 7,255,087 | 14.85B |
| 38 | ARGX | argenx SE | 43.43B | -0.21% | 419,033 | 4.24B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.09B | -3.29% | 815,892 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.14B | -1.52% | 1,543,322 | 10.40B |
| 41 | TEVA | Teva Pharmaceutical Industries Limited | 33.47B | -3.49% | 6,014,331 | 17.26B |
| 42 | RMD | ResMed Inc. | 31.98B | -0.91% | 984,959 | 5.40B |
| 43 | GEHC | GE HealthCare Technologies Inc. | 31.59B | -3.23% | 3,524,345 | 20.63B |
| 44 | ONC | BeOne Medicines AG | 31.38B | 2.20% | 233,828 | 5.34B |
| 45 | INSM | Insmed Incorporated | 31.32B | -1.56% | 3,402,099 | 606.42M |
| 46 | A | Agilent Technologies, Inc. | 31.15B | -2.86% | 1,269,660 | 7.07B |
| 47 | WAT | Waters Corporation | 28.37B | -3.79% | 848,343 | 3.17B |
| 48 | VEEV | Veeva Systems Inc. | 28.19B | -3.19% | 1,495,538 | 3.20B |
| 49 | IQV | IQVIA Holdings Inc. | 27.50B | -3.28% | 1,526,799 | 16.31B |
| 50 | BIIB | Biogen Inc. | 26.98B | -3.78% | 934,916 | 9.89B |
| 51 | RPRX | Royalty Pharma plc | 26.74B | -1.26% | 2,710,159 | 2.38B |
| 52 | NTRA | Natera, Inc. | 25.89B | -6.88% | 1,063,048 | 2.31B |
| 53 | PHG | Koninklijke Philips N.V. | 25.73B | -1.33% | 936,359 | 20.94B |
| 54 | MTD | Mettler-Toledo International Inc. | 24.95B | -2.99% | 159,659 | 4.03B |
| 55 | DXCM | DexCom, Inc. | 23.96B | -5.81% | 4,309,895 | 4.66B |
| 56 | UTHR | United Therapeutics Corporation | 22.91B | -1.82% | 338,332 | 3.18B |
| 57 | LH | Labcorp Holdings Inc. | 21.77B | -1.56% | 594,455 | 13.95B |
| 58 | STE | STERIS plc | 21.52B | -1.80% | 860,041 | 5.83B |
| 59 | DGX | Quest Diagnostics Incorporated | 21.48B | -1.33% | 976,313 | 11.04B |
| 60 | BNTX | BioNTech SE | 20.56B | -2.04% | 705,981 | 3.37B |
| 61 | HUM | Humana Inc. | 20.30B | -2.96% | 1,682,276 | 129.66B |
| 62 | MRNA | Moderna, Inc. | 19.65B | -7.49% | 7,098,932 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 18.98B | -3.03% | 3,012,871 | 13.31M |
| 64 | RVMD | Revolution Medicines, Inc. | 18.33B | -0.75% | 1,102,724 | - |
| 65 | ILMN | Illumina, Inc. | 17.99B | -5.41% | 1,223,772 | 4.34B |
| 66 | INCY | Incyte Corporation | 17.97B | -2.12% | 1,494,336 | 5.14B |
| 67 | WST | West Pharmaceutical Services, Inc. | 17.53B | -1.92% | 823,521 | 3.07B |
| 68 | ZBH | Zimmer Biomet Holdings, Inc. | 17.33B | -0.65% | 2,273,420 | 8.23B |
| 69 | HOLX | Hologic, Inc. | 16.89B | -0.03% | 2,092,727 | 4.13B |
| 70 | THC | Tenet Healthcare Corporation | 16.68B | -1.84% | 603,523 | 21.31B |
| 71 | GMAB | Genmab A/S | 15.93B | -0.81% | 1,816,056 | 3.72B |
| 72 | CNC | Centene Corporation | 15.74B | -4.65% | 8,570,765 | 176.15B |
| 73 | VTRS | Viatris Inc. | 15.03B | -2.39% | 4,994,527 | 14.30B |
| 74 | PODD | Insulet Corporation | 14.66B | -4.53% | 897,777 | 2.71B |
| 75 | COO | The Cooper Companies, Inc. | 13.61B | -2.47% | 1,638,022 | 4.15B |
| 76 | BBIO | BridgeBio Pharma, Inc. | 13.51B | -3.97% | 1,225,204 | 502.08M |
| 77 | SNN | Smith & Nephew plc | 13.47B | -0.51% | 964,017 | 6.16B |
| 78 | ASND | Ascendis Pharma A/S | 13.32B | -1.65% | 580,803 | 845.52M |
| 79 | PEN | Penumbra, Inc. | 13.15B | -0.39% | 559,642 | 1.40B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 12.88B | -3.10% | 760,310 | 2.86B |
| 81 | SMMT | Summit Therapeutics Inc. | 12.86B | -3.94% | 2,079,560 | - |
| 82 | MEDP | Medpace Holdings, Inc. | 12.81B | -3.30% | 215,407 | 2.53B |
| 83 | RGC | Regencell Bioscience Holdings Limited | 12.69B | 1.06% | 193,983 | - |
| 84 | FMS | Fresenius Medical Care AG | 12.05B | -1.47% | 284,420 | 23.05B |
| 85 | IONS | Ionis Pharmaceuticals, Inc. | 11.92B | -2.82% | 1,948,253 | 943.71M |
| 86 | ALGN | Align Technology, Inc. | 11.86B | -6.17% | 1,294,071 | 4.03B |
| 87 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.71B | -1.56% | 487,137 | 958.40M |
| 88 | ENSG | The Ensign Group, Inc. | 11.57B | -0.66% | 346,060 | 5.06B |
| 89 | ELAN | Elanco Animal Health Incorporated | 11.50B | -5.90% | 5,441,235 | 4.72B |
| 90 | GMED | Globus Medical, Inc. | 11.33B | -3.14% | 994,977 | 2.94B |
| 91 | RDY | Dr. Reddy's Laboratories Limited | 11.25B | -2.11% | 1,366,837 | 3.85B |
| 92 | JAZZ | Jazz Pharmaceuticals plc | 11.25B | -3.42% | 826,952 | 4.27B |
| 93 | UHS | Universal Health Services, Inc. | 11.24B | -0.57% | 581,105 | 17.36B |
| 94 | GH | Guardant Health, Inc. | 11.10B | -3.96% | 2,180,843 | 982.02M |
| 95 | SOLV | Solventum Corporation | 10.89B | -3.01% | 1,354,569 | 8.33B |
| 96 | EXEL | Exelixis, Inc. | 10.79B | -1.96% | 1,762,429 | 2.32B |
| 97 | BMRN | BioMarin Pharmaceutical Inc. | 10.41B | -2.54% | 1,345,747 | 3.22B |
| 98 | DVA | DaVita Inc. | 10.31B | -1.49% | 575,052 | 13.64B |
| 99 | EHC | Encompass Health Corporation | 9.70B | -0.17% | 776,318 | 5.94B |
| 100 | RVTY | Revvity, Inc. | 9.38B | -3.70% | 835,221 | 2.86B |
| 101 | MASI | Masimo Corporation | 9.25B | 0.12% | 1,133,502 | 1.53B |
| 102 | BTSG | BrightSpring Health Services, Inc. | 8.64B | -1.17% | 2,245,326 | 12.91B |
| 103 | HSIC | Henry Schein, Inc. | 8.27B | -2.18% | 982,651 | 13.18B |
| 104 | BAX | Baxter International Inc. | 8.24B | -4.20% | 6,517,253 | 11.24B |
| 105 | ABVX | ABIVAX Société Anonyme | 8.14B | -6.40% | 1,757,499 | 5.37M |
| 106 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.09B | -4.92% | 1,650,505 | 1.09B |
| 107 | PRAX | Praxis Precision Medicines, Inc. | 8.08B | -4.16% | 398,727 | 7.46M |
| 108 | QGEN | Qiagen N.V. | 8.05B | -1.61% | 1,415,474 | 2.09B |
| 109 | AXSM | Axsome Therapeutics, Inc. | 8.00B | -4.82% | 680,798 | 638.50M |
| 110 | TECH | Bio-Techne Corporation | 7.97B | -3.32% | 1,787,407 | 1.22B |
| 111 | ATR | AptarGroup, Inc. | 7.85B | -2.17% | 381,346 | 3.78B |
| 112 | CRL | Charles River Laboratories International, Inc. | 7.84B | -3.62% | 814,218 | 4.02B |
| 113 | ICLR | ICON Public Limited Company | 7.79B | -0.97% | 1,045,774 | 8.10B |
| 114 | CYTK | Cytokinetics, Incorporated | 7.70B | -1.54% | 1,701,712 | 88.04M |
| 115 | PCVX | Vaxcyte, Inc. | 7.65B | -2.83% | 995,884 | - |
| 116 | TEM | Tempus AI, Inc. | 7.62B | -6.39% | 5,705,485 | 1.27B |
| 117 | NUVL | Nuvalent, Inc. | 7.60B | -1.43% | 482,661 | - |
| 118 | IBRX | ImmunityBio, Inc. | 7.59B | - | 14,454,915 | 113.29M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.30B | -2.62% | 1,282,880 | 1.40B |
| 120 | KRYS | Krystal Biotech, Inc. | 7.17B | -2.39% | 289,700 | 389.13M |
| 121 | BIO | Bio-Rad Laboratories, Inc. | 7.16B | -4.02% | 339,726 | 2.58B |
| 122 | MOH | Molina Healthcare, Inc. | 6.98B | -3.44% | 1,056,463 | 43.56B |
| 123 | HQY | HealthEquity, Inc. | 6.97B | -1.60% | 835,088 | 1.31B |
| 124 | ACLX | Arcellx, Inc. | 6.72B | -0.04% | 1,653,379 | 22.29M |
| 125 | KYMR | Kymera Therapeutics, Inc. | 6.38B | -2.52% | 671,414 | 39.21M |
| 126 | PTGX | Protagonist Therapeutics, Inc. | 6.32B | -3.13% | 785,488 | 46.02M |
| 127 | RGEN | Repligen Corporation | 6.20B | -3.76% | 826,857 | 738.26M |
| 128 | GRFS | Grifols, S.A. | 6.20B | -1.71% | 873,891 | 8.83B |
| 129 | GKOS | Glaukos Corporation | 5.99B | -4.24% | 625,300 | 507.44M |
| 130 | BLTE | Belite Bio, Inc | 5.98B | 1.94% | 109,773 | - |
| 131 | TERN | Terns Pharmaceuticals, Inc. | 5.98B | -0.47% | 7,922,820 | - |
| 132 | COGT | Cogent Biosciences, Inc. | 5.81B | -2.09% | 1,542,830 | - |
| 133 | APGE | Apogee Therapeutics, Inc. | 5.75B | -0.77% | 1,529,257 | - |
| 134 | PTCT | PTC Therapeutics, Inc. | 5.47B | -1.30% | 1,036,445 | 1.73B |
| 135 | CGON | CG Oncology, Inc. | 5.46B | -3.07% | 889,230 | 4.04M |
| 136 | BLCO | Bausch + Lomb Corporation | 5.45B | -3.27% | 316,503 | 5.10B |
| 137 | MIRM | Mirum Pharmaceuticals, Inc. | 5.34B | -0.50% | 969,246 | 521.31M |
| 138 | XENE | Xenon Pharmaceuticals Inc. | 5.20B | -1.89% | 966,676 | 7.50M |
| 139 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.18B | -7.42% | 1,424,817 | 189.76M |
| 140 | TFX | Teleflex Incorporated | 5.14B | 5.19% | 1,097,264 | 1.99B |
| 141 | BRKR | Bruker Corporation | 5.13B | -4.58% | 1,982,054 | 3.44B |
| 142 | CELC | Celcuity Inc. | 5.12B | -7.66% | 1,074,236 | - |
| 143 | CHE | Chemed Corporation | 5.07B | -0.90% | 288,791 | 2.53B |
| 144 | AVTR | Avantor, Inc. | 5.05B | -3.39% | 7,060,783 | 6.55B |
| 145 | ALKS | Alkermes plc | 4.90B | -1.77% | 2,072,670 | 1.48B |
| 146 | SRRK | Scholar Rock Holding Corporation | 4.89B | -3.64% | 1,056,895 | - |
| 147 | IMVT | Immunovant, Inc. | 4.88B | -5.44% | 1,133,121 | - |
| 148 | LNTH | Lantheus Holdings, Inc. | 4.84B | -2.48% | 488,080 | 1.54B |
| 149 | PACS | PACS Group, Inc. | 4.81B | -5.41% | 821,868 | 5.29B |
| 150 | CAI | Caris Life Sciences, Inc. | 4.79B | -7.53% | 3,710,972 | 812.03M |
| 151 | TGTX | TG Therapeutics, Inc. | 4.69B | -0.72% | 1,523,772 | 616.29M |
| 152 | ERAS | Erasca, Inc. | 4.65B | -1.25% | 3,870,212 | - |
| 153 | FOLD | Amicus Therapeutics, Inc. | 4.52B | -0.14% | 2,288,924 | 634.21M |
| 154 | WAY | Waystar Holding Corp. | 4.51B | -5.27% | 2,358,843 | 1.10B |
| 155 | HIMS | Hims & Hers Health, Inc. | 4.42B | -7.09% | 22,373,769 | 2.35B |
| 156 | CRSP | CRISPR Therapeutics AG | 4.39B | -3.79% | 1,594,424 | 3.51M |
| 157 | DOCS | Doximity, Inc. | 4.38B | -2.55% | 2,082,049 | 637.78M |
| 158 | RDNT | RadNet, Inc. | 4.36B | -5.49% | 868,313 | 2.04B |
| 159 | DNTH | Dianthus Therapeutics, Inc. | 4.30B | -1.60% | 1,689,173 | 2.04M |
| 160 | OPCH | Option Care Health, Inc. | 4.27B | -1.73% | 1,278,187 | 5.65B |
| 161 | CNTA | Centessa Pharmaceuticals plc | 4.19B | -2.38% | 1,385,352 | 15.00M |
| 162 | MMSI | Merit Medical Systems, Inc. | 4.08B | -0.84% | 735,755 | 1.52B |
| 163 | MMED | Minimed Group, Inc. | 4.06B | -5.24% | 725,603 | 2.89B |
| 164 | NVST | Envista Holdings Corporation | 4.03B | -4.80% | 3,264,865 | 2.72B |
| 165 | CORT | Corcept Therapeutics Incorporated | 4.00B | -2.41% | 1,775,226 | 761.41M |
| 166 | LGND | Ligand Pharmaceuticals Incorporated | 3.90B | -4.04% | 268,255 | 268.09M |
| 167 | IRTC | iRhythm Holdings, Inc. | 3.82B | -3.83% | 463,039 | 747.14M |
| 168 | AMRX | Amneal Pharmaceuticals, Inc. | 3.78B | -1.74% | 1,146,090 | 3.02B |
| 169 | VKTX | Viking Therapeutics, Inc. | 3.76B | -5.05% | 2,251,288 | - |
| 170 | SHC | Sotera Health Company | 3.73B | -3.03% | 2,780,169 | 1.16B |
| 171 | SYRE | Spyre Therapeutics, Inc. | 3.72B | -0.44% | 832,414 | - |
| 172 | STVN | Stevanato Group S.p.A. | 3.67B | -1.40% | 1,627,259 | 1.39B |
| 173 | ACAD | ACADIA Pharmaceuticals Inc. | 3.54B | -3.35% | 1,214,753 | 1.07B |
| 174 | CRNX | Crinetics Pharmaceuticals, Inc. | 3.53B | -7.27% | 1,461,482 | 7.70M |
| 175 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.50B | -2.20% | 974,267 | 677.56M |
| 176 | NAMS | NewAmsterdam Pharma Company N.V. | 3.45B | -4.06% | 743,739 | 22.50M |
| 177 | TMDX | TransMedics Group, Inc. | 3.40B | -3.08% | 807,824 | 605.49M |
| 178 | ALHC | Alignment Healthcare, Inc. | 3.40B | -1.71% | 2,308,964 | 3.95B |
| 179 | LIVN | LivaNova PLC | 3.38B | -2.83% | 766,203 | 1.39B |
| 180 | OSCR | Oscar Health, Inc. | 3.31B | -5.91% | 8,312,634 | 11.70B |
| 181 | EWTX | Edgewise Therapeutics, Inc. | 3.31B | -2.56% | 565,574 | - |
| 182 | BKD | Brookdale Senior Living Inc. | 3.29B | 0.66% | 2,607,799 | 3.05B |
| 183 | GPCR | Structure Therapeutics Inc. | 3.25B | -0.61% | 1,299,952 | - |
| 184 | BLLN | BillionToOne, Inc. | 3.20B | -2.65% | 302,501 | 305.11M |
| 185 | TLX | Telix Pharmaceuticals Limited | 3.19B | 2.56% | 269,328 | 803.79M |
| 186 | ALMS | Alumis Inc. | 3.15B | -5.78% | 1,549,317 | 24.05M |
| 187 | LEGN | Legend Biotech Corporation | 3.11B | -3.95% | 1,307,503 | 1.03B |
| 188 | ICUI | ICU Medical, Inc. | 3.10B | -2.71% | 232,516 | 2.23B |
| 189 | LQDA | Liquidia Corporation | 3.09B | -4.73% | 954,906 | 158.32M |
| 190 | ITGR | Integer Holdings Corporation | 2.94B | -1.73% | 343,302 | 1.85B |
| 191 | DNLI | Denali Therapeutics Inc. | 2.88B | -8.00% | 3,068,747 | - |
| 192 | CPRX | Catalyst Pharmaceuticals, Inc. | 2.86B | -3.51% | 754,767 | 588.99M |
| 193 | HNGE | Hinge Health, Inc. | 2.86B | -9.78% | 1,477,024 | 587.86M |
| 194 | SUPN | Supernus Pharmaceuticals, Inc. | 2.85B | -2.52% | 549,268 | 718.95M |
| 195 | DYN | Dyne Therapeutics, Inc. | 2.83B | -7.60% | 1,763,867 | - |
| 196 | TARS | Tarsus Pharmaceuticals, Inc. | 2.82B | -1.41% | 356,356 | 451.36M |
| 197 | PBH | Prestige Consumer Healthcare Inc. | 2.80B | -1.92% | 490,318 | 1.10B |
| 198 | VRDN | Viridian Therapeutics, Inc. | 2.80B | -2.87% | 1,413,338 | 70.85M |
| 199 | VERA | Vera Therapeutics, Inc. | 2.77B | -3.48% | 763,120 | - |
| 200 | TNGX | Tango Therapeutics, Inc. | 2.75B | -3.02% | 1,836,172 | 62.38M |
| 201 | TWST | Twist Bioscience Corporation | 2.73B | -4.75% | 1,076,448 | 391.56M |
| 202 | CON | Concentra Group Holdings Parent, Inc. | 2.71B | -2.67% | 866,093 | 2.16B |
| 203 | IDYA | IDEAYA Biosciences, Inc. | 2.67B | -5.08% | 693,897 | 218.71M |
| 204 | ARQT | Arcutis Biotherapeutics, Inc. | 2.63B | -5.18% | 1,357,045 | 376.07M |
| 205 | RCUS | Arcus Biosciences, Inc. | 2.54B | -4.38% | 734,637 | 247.00M |
| 206 | TVTX | Travere Therapeutics, Inc. | 2.51B | -2.40% | 633,440 | 490.73M |
| 207 | HAE | Haemonetics Corporation | 2.51B | -2.67% | 1,649,839 | 1.32B |
| 208 | NHC | National HealthCare Corporation | 2.50B | -0.16% | 133,745 | 1.52B |
| 209 | WRBY | Warby Parker Inc. | 2.49B | -7.55% | 3,249,593 | 871.91M |
| 210 | TXG | 10x Genomics, Inc. | 2.49B | -4.65% | 2,052,549 | 642.82M |
| 211 | PRVA | Privia Health Group, Inc. | 2.48B | -0.79% | 968,810 | 2.12B |
| 212 | LFST | LifeStance Health Group, Inc. | 2.46B | -5.53% | 1,712,503 | 1.42B |
| 213 | MANE | Veradermics, Incorporated | 2.45B | -2.99% | 261,758 | - |
| 214 | LMAT | LeMaitre Vascular, Inc. | 2.43B | -3.36% | 319,143 | 249.60M |
| 215 | VCYT | Veracyte, Inc. | 2.38B | -8.51% | 1,499,981 | 517.15M |
| 216 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.34B | -2.41% | 4,324,559 | 874.84M |
| 217 | ELVN | Enliven Therapeutics, Inc. | 2.32B | -1.17% | 1,347,898 | - |
| 218 | IRON | Disc Medicine, Inc. | 2.29B | -3.10% | 318,198 | - |
| 219 | KOD | Kodiak Sciences Inc. | 2.29B | -6.94% | 5,262,726 | - |
| 220 | XRAY | DENTSPLY SIRONA Inc. | 2.29B | -1.71% | 3,828,133 | 3.68B |
| 221 | HCM | HUTCHMED (China) Limited | 2.25B | -2.51% | 28,386 | 548.51M |
| 222 | IMNM | Immunome, Inc. | 2.22B | -3.92% | 1,189,158 | 6.94M |
| 223 | DAWN | Day One Biopharmaceuticals, Inc. | 2.21B | 0.05% | 2,368,063 | 158.18M |
| 224 | BEAM | Beam Therapeutics Inc. | 2.20B | -6.05% | 2,626,267 | 139.74M |
| 225 | ORKA | Oruka Therapeutics, Inc. | 2.20B | -2.16% | 885,313 | - |
| 226 | ADMA | ADMA Biologics, Inc. | 2.20B | 11.58% | 22,370,956 | 510.17M |
| 227 | PAHC | Phibro Animal Health Corporation | 2.18B | -3.48% | 373,792 | 1.46B |
| 228 | APLS | Apellis Pharmaceuticals, Inc. | 2.17B | -3.80% | 1,762,706 | 1.00B |
| 229 | GRDN | Guardian Pharmacy Services, Inc. | 2.16B | -3.50% | 797,061 | 1.45B |
| 230 | AAPG | Ascentage Pharma Group International | 2.16B | 8.17% | 3,751 | 82.08M |
| 231 | HTFL | HeartFlow, Inc. | 2.12B | -4.60% | 1,486,992 | 176.03M |
| 232 | ACHC | Acadia Healthcare Company, Inc. | 2.11B | -3.94% | 3,457,914 | 3.31B |
| 233 | SRPT | Sarepta Therapeutics, Inc. | 2.10B | -7.89% | 4,609,413 | 2.20B |
| 234 | SNDX | Syndax Pharmaceuticals, Inc. | 2.07B | -4.90% | 1,234,523 | 172.35M |
| 235 | AHG | Akso Health Group | 2.02B | -1.91% | 200,680 | 14.84M |
| 236 | SEM | Select Medical Holdings Corporation | 2.02B | - | 822,974 | 5.45B |
| 237 | ZLAB | Zai Lab Limited | 2.02B | 2.80% | 691,911 | 460.16M |
| 238 | CLDX | Celldex Therapeutics, Inc. | 2.02B | -4.57% | 904,818 | 1.55M |
| 239 | GRAL | GRAIL, Inc. | 1.99B | -7.04% | 732,256 | 147.17M |
| 240 | NKTR | Nektar Therapeutics | 1.97B | -3.25% | 735,798 | 55.23M |
| 241 | TYRA | Tyra Biosciences, Inc. | 1.95B | -4.58% | 671,875 | - |
| 242 | MLYS | Mineralys Therapeutics, Inc. | 1.95B | 0.30% | 1,443,735 | - |
| 243 | STOK | Stoke Therapeutics, Inc. | 1.94B | -2.52% | 500,645 | 184.42M |
| 244 | GLPG | Galapagos NV | 1.93B | -3.47% | 371,321 | 1.31B |
| 245 | ADPT | Adaptive Biotechnologies Corporation | 1.91B | -11.10% | 4,947,809 | 276.98M |
| 246 | AUPH | Aurinia Pharmaceuticals Inc. | 1.90B | -2.26% | 1,130,886 | 283.06M |
| 247 | NEOG | Neogen Corporation | 1.89B | -4.92% | 1,810,891 | 880.32M |
| 248 | MESO | Mesoblast Limited | 1.88B | -3.36% | 176,068 | 65.38M |
| 249 | RARE | Ultragenyx Pharmaceutical Inc. | 1.87B | -3.10% | 1,529,974 | 673.00M |
| 250 | BHC | Bausch Health Companies Inc. | 1.86B | -1.95% | 1,190,614 | 10.27B |
| 251 | ZYME | Zymeworks Inc. | 1.78B | -2.07% | 429,429 | 105.97M |
| 252 | DFTX | Definium Therapeutics, Inc. | 1.78B | -5.60% | 1,742,740 | - |
| 253 | PHVS | Pharvaris N.V. | 1.78B | 0.04% | 55,922 | - |
| 254 | ADUS | Addus HomeCare Corporation | 1.73B | -2.54% | 186,568 | 1.42B |
| 255 | AGIO | Agios Pharmaceuticals, Inc. | 1.72B | -1.74% | 797,075 | 54.03M |
| 256 | RLAY | Relay Therapeutics, Inc. | 1.72B | -5.14% | 2,078,803 | 15.36M |
| 257 | AORT | Artivion, Inc. | 1.69B | -3.02% | 259,028 | 441.33M |
| 258 | INVA | Innoviva, Inc. | 1.68B | - | 496,970 | 411.33M |
| 259 | WGS | GeneDx Holdings Corp. | 1.67B | -6.94% | 1,162,882 | 427.54M |
| 260 | MD | Pediatrix Medical Group, Inc. | 1.66B | -2.29% | 790,890 | 1.91B |
| 261 | CAPR | Capricor Therapeutics, Inc. | 1.66B | -3.51% | 909,350 | 11.13M |
| 262 | ATEC | Alphatec Holdings, Inc. | 1.65B | -5.12% | 1,950,634 | 764.16M |
| 263 | ANAB | AnaptysBio, Inc. | 1.65B | -11.68% | 1,353,316 | 234.60M |
| 264 | OCUL | Ocular Therapeutix, Inc. | 1.64B | -6.44% | 2,822,709 | 51.95M |
| 265 | SION | Sionna Therapeutics, Inc. | 1.63B | -4.93% | 497,922 | - |
| 266 | AXGN | Axogen, Inc. | 1.62B | -3.01% | 805,192 | 225.21M |
| 267 | ESTA | Establishment Labs Holdings Inc. | 1.62B | -7.68% | 612,988 | 211.08M |
| 268 | RXRX | Recursion Pharmaceuticals, Inc. | 1.55B | -6.67% | 19,285,924 | 74.68M |
| 269 | SLNO | Soleno Therapeutics, Inc. | 1.55B | -5.68% | 1,755,947 | 190.41M |
| 270 | DMRA | Damora Therapeutics, Inc. | 1.54B | -0.51% | 171,714 | - |
| 271 | HRMY | Harmony Biosciences Holdings, Inc. | 1.54B | -3.28% | 683,688 | 868.45M |
| 272 | AHCO | AdaptHealth Corp. | 1.52B | -1.84% | 772,494 | 3.24B |
| 273 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | -1.78% | 117,614 | 883.37M |
| 274 | OGN | Organon & Co. | 1.52B | -3.47% | 2,931,025 | 6.22B |
| 275 | NRIX | Nurix Therapeutics, Inc. | 1.52B | -4.96% | 1,177,855 | 83.98M |
| 276 | MAZE | Maze Therapeutics, Inc. | 1.51B | -4.19% | 1,713,764 | 2.50M |
| 277 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.50B | 0.59% | 1,216,715 | -665.00K |
| 278 | VCEL | Vericel Corporation | 1.49B | -4.80% | 732,677 | 276.26M |
| 279 | IMCR | Immunocore Holdings plc | 1.49B | -3.51% | 382,919 | 400.02M |
| 280 | OMCL | Omnicell, Inc. | 1.49B | -6.96% | 443,218 | 1.18B |
| 281 | PRCT | PROCEPT BioRobotics Corporation | 1.49B | 5.15% | 2,053,408 | 308.05M |
| 282 | NBTX | Nanobiotix S.A. | 1.48B | -3.44% | 58,700 | 11.93M |
| 283 | SNDA | Sonida Senior Living, Inc. | 1.48B | 0.70% | 665,575 | 336.39M |
| 284 | SGRY | Surgery Partners, Inc. | 1.47B | -3.04% | 778,203 | 3.31B |
| 285 | NTLA | Intellia Therapeutics, Inc. | 1.46B | -6.57% | 3,735,320 | 67.67M |
| 286 | UFPT | UFP Technologies, Inc. | 1.46B | 0.78% | 143,011 | 602.80M |
| 287 | OCS | Oculis Holding AG | 1.46B | -1.20% | 126,145 | 1.51M |
| 288 | GENB | Generate Biomedicines, Inc. | 1.46B | -10.97% | 298,012 | 31.89M |
| 289 | NUVB | Nuvation Bio Inc. | 1.46B | -3.85% | 4,154,475 | 62.90M |
| 290 | TRVI | Trevi Therapeutics, Inc. | 1.45B | -3.98% | 1,429,336 | - |
| 291 | IOVA | Iovance Biotherapeutics, Inc. | 1.45B | -4.88% | 8,496,846 | 263.50M |
| 292 | INSP | Inspire Medical Systems, Inc. | 1.44B | -0.63% | 758,116 | 911.98M |
| 293 | ATRC | AtriCure, Inc. | 1.44B | -3.86% | 304,578 | 534.53M |
| 294 | TNDM | Tandem Diabetes Care, Inc. | 1.43B | -9.95% | 2,389,459 | 1.01B |
| 295 | PGNY | Progyny, Inc. | 1.41B | -2.92% | 824,904 | 1.29B |
| 296 | PLSE | Pulse Biosciences, Inc. | 1.40B | -4.33% | 121,410 | 350.00K |
| 297 | NVAX | Novavax, Inc. | 1.38B | -5.59% | 3,942,281 | 1.12B |
| 298 | AVAH | Aveanna Healthcare Holdings Inc. | 1.37B | -4.84% | 703,793 | 2.43B |
| 299 | MBX | MBX Biosciences, Inc. | 1.35B | 0.74% | 352,809 | - |
| 300 | ARDX | Ardelyx, Inc. | 1.34B | -3.69% | 2,520,454 | 407.32M |
| 301 | VIR | Vir Biotechnology, Inc. | 1.34B | -6.25% | 1,459,157 | 68.56M |
| 302 | RAPP | Rapport Therapeutics, Inc. | 1.33B | -4.00% | 291,570 | - |
| 303 | PVLA | Palvella Therapeutics, Inc. | 1.33B | -4.46% | 229,062 | - |
| 304 | PRGO | Perrigo Company plc | 1.31B | 1.60% | 2,850,063 | 4.25B |
| 305 | SVRA | Savara Inc. | 1.30B | -2.10% | 1,550,983 | - |
| 306 | HCSG | Healthcare Services Group, Inc. | 1.30B | -3.24% | 430,196 | 1.84B |
| 307 | PGEN | Precigen, Inc. | 1.30B | -5.66% | 7,072,136 | 9.68M |
| 308 | HROW | Harrow, Inc. | 1.26B | -4.38% | 758,897 | 272.30M |
| 309 | BHVN | Biohaven Ltd. | 1.26B | -6.17% | 1,646,590 | - |
| 310 | IMTX | Immatics N.V. | 1.26B | -4.09% | 313,125 | 56.67M |
| 311 | ENOV | Enovis Corporation | 1.25B | -6.63% | 636,561 | 2.25B |
| 312 | NVCR | NovoCure Limited | 1.25B | -6.72% | 1,213,587 | 655.35M |
| 313 | IRMD | IRADIMED CORPORATION | 1.24B | -1.40% | 70,066 | 83.81M |
| 314 | MLTX | MoonLake Immunotherapeutics | 1.24B | -2.42% | 478,952 | - |
| 315 | GLUE | Monte Rosa Therapeutics, Inc. | 1.23B | -1.85% | 1,211,406 | 123.67M |
| 316 | ARDT | Ardent Health, Inc. | 1.23B | -2.16% | 278,633 | 6.32B |
| 317 | ATAI | AtaiBeckley Inc. | 1.22B | -5.37% | 3,254,031 | 4.09M |
| 318 | ORIC | ORIC Pharmaceuticals, Inc. | 1.21B | -2.58% | 1,347,015 | - |
| 319 | WVE | Wave Life Sciences Ltd. | 1.20B | 2.66% | 13,490,099 | 42.73M |
| 320 | ASTH | Astrana Health, Inc. | 1.20B | -0.33% | 333,253 | 3.18B |
| 321 | BCAX | Bicara Therapeutics Inc. | 1.19B | -2.91% | 588,807 | - |
| 322 | OLMA | Olema Pharmaceuticals, Inc. | 1.19B | -3.19% | 1,203,803 | - |
| 323 | CRVS | Corvus Pharmaceuticals, Inc. | 1.18B | -0.43% | 1,114,049 | - |
| 324 | TSHA | Taysha Gene Therapies, Inc. | 1.17B | -5.79% | 2,277,045 | 9.77M |
| 325 | KMTS | Kestra Medical Technologies, Ltd. | 1.14B | -1.12% | 268,587 | 83.72M |
| 326 | DBVT | DBV Technologies S.A. | 1.13B | -1.04% | 275,602 | 5.64M |
| 327 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 0.44% | 240,928 | 773.34M |
| 328 | PHAR | Pharming Group N.V. | 1.12B | - | 26,533 | 376.13M |
| 329 | IVA | Inventiva S.A. | 1.10B | -5.58% | 179,435 | 19.93M |
| 330 | INNV | InnovAge Holding Corp. | 1.07B | -0.13% | 268,716 | 915.37M |
| 331 | SEPN | Septerna, Inc. | 1.07B | -3.52% | 145,381 | 45.95M |
| 332 | CNMD | CONMED Corporation | 1.07B | -5.62% | 382,078 | 1.37B |
| 333 | NNNN | Anbio Biotechnology | 1.05B | 3.10% | 28,679 | 6.92M |
| 334 | ZBIO | Zenas BioPharma, Inc. | 1.04B | -17.82% | 3,367,079 | 10.00M |
| 335 | EYPT | EyePoint, Inc. | 1.04B | -4.29% | 843,539 | 31.37M |
| 336 | PNTG | The Pennant Group, Inc. | 1.03B | -2.36% | 221,312 | 947.71M |
| 337 | COLL | Collegium Pharmaceutical, Inc. | 1.03B | -2.93% | 659,318 | 780.57M |
| 338 | QDEL | QuidelOrtho Corporation | 1.01B | -5.26% | 2,166,177 | 2.73B |
| 339 | BFLY | Butterfly Network, Inc. | 998.16M | -5.54% | 3,562,673 | 97.61M |
| 340 | ABCL | AbCellera Biologics Inc. | 991.33M | -2.39% | 2,368,603 | 75.13M |
| 341 | KALV | KalVista Pharmaceuticals, Inc. | 990.13M | 2.01% | 2,063,368 | 73.62M |
| 342 | PCRX | Pacira BioSciences, Inc. | 984.33M | -1.84% | 494,321 | 726.41M |
| 343 | SSII | SS Innovations International, Inc. | 981.71M | -0.41% | 22,936 | 42.48M |
| 344 | CTMX | CytomX Therapeutics, Inc. | 977.12M | 2.26% | 7,537,407 | 76.20M |
| 345 | ALVO | Alvotech | 973.49M | -4.01% | 317,839 | 588.90M |
| 346 | CRON | Cronos Group Inc. | 950.89M | -0.79% | 778,856 | 146.59M |
| 347 | AVBP | ArriVent BioPharma, Inc. | 947.24M | -1.60% | 420,198 | - |
| 348 | CMPX | Compass Therapeutics, Inc. | 938.26M | -2.25% | 1,355,901 | 850.00K |
| 349 | NEO | NeoGenomics, Inc. | 933.35M | -7.35% | 1,703,599 | 727.33M |
| 350 | XERS | Xeris Biopharma Holdings, Inc. | 931.13M | -3.05% | 1,364,204 | 291.85M |
| 351 | QURE | uniQure N.V. | 923.56M | -5.32% | 1,359,874 | 16.10M |
| 352 | CLOV | Clover Health Investments, Corp. | 918.17M | -2.78% | 3,694,280 | 1.92B |
| 353 | TDOC | Teladoc Health, Inc. | 916.96M | -6.88% | 4,535,195 | 2.53B |
| 354 | AZTA | Azenta, Inc. | 916.62M | -6.62% | 751,116 | 595.03M |
| 355 | CERT | Certara, Inc. | 915.05M | -6.35% | 4,115,817 | 418.84M |
| 356 | BLFS | BioLife Solutions, Inc. | 897.90M | -5.39% | 395,881 | 96.21M |
| 357 | GERN | Geron Corporation | 896.76M | -9.09% | 19,251,941 | 183.88M |
| 358 | STAA | STAAR Surgical Company | 885.78M | -4.02% | 736,132 | 239.44M |
| 359 | EVO | Evotec SE | 879.46M | -1.63% | 48,448 | 887.40M |
| 360 | AMPH | Amphastar Pharmaceuticals, Inc. | 862.49M | -2.66% | 345,915 | 719.89M |
| 361 | TALK | Talkspace, Inc. | 860.44M | - | 5,895,920 | 228.87M |
| 362 | CDNA | CareDx, Inc. | 859.41M | -3.95% | 551,531 | 379.81M |
| 363 | INBX | Inhibrx Biosciences, Inc. | 852.90M | -11.25% | 293,812 | 1.30M |
| 364 | OPK | OPKO Health, Inc. | 850.16M | -4.27% | 3,472,750 | 606.88M |
| 365 | INMD | InMode Ltd. | 849.01M | -2.55% | 985,424 | 370.50M |
| 366 | FTRE | Fortrea Holdings Inc. | 848.05M | -5.03% | 797,529 | 2.72B |
| 367 | ABUS | Arbutus Biopharma Corporation | 838.60M | -3.60% | 1,383,296 | 14.08M |
| 368 | XNCR | Xencor, Inc. | 837.53M | -7.23% | 845,999 | 125.58M |
| 369 | URGN | UroGen Pharma Ltd. | 835.87M | -4.08% | 827,277 | 109.79M |
| 370 | PHAT | Phathom Pharmaceuticals, Inc. | 833.69M | -1.95% | 1,502,478 | 175.11M |
| 371 | SDGR | Schrödinger, Inc. | 817.98M | -4.24% | 994,011 | 255.87M |
| 372 | MPLT | MapLight Therapeutics, Inc. | 816.65M | -3.07% | 275,932 | - |
| 373 | GHRS | GH Research PLC | 815.69M | -6.67% | 87,784 | - |
| 374 | JANX | Janux Therapeutics, Inc. | 801.76M | -3.30% | 1,454,800 | 10.00M |
| 375 | SPRY | ARS Pharmaceuticals, Inc. | 801.33M | -5.72% | 2,382,159 | 84.28M |
| 376 | EVMN | Evommune, Inc. | 798.89M | -6.29% | 201,087 | 13.00M |
| 377 | AKTS | Aktis Oncology, Inc. | 797.81M | -13.79% | 577,073 | 5.56M |
| 378 | SLS | SELLAS Life Sciences Group, Inc. | 783.88M | -11.82% | 10,173,363 | - |
| 379 | CGEM | Cullinan Therapeutics, Inc. | 777.76M | -6.00% | 607,569 | - |
| 380 | TBPH | Theravance Biopharma, Inc. | 776.51M | -0.72% | 574,141 | 107.46M |
| 381 | SGP | SpyGlass Pharma, Inc. | 753.31M | -10.28% | 95,373 | - |
| 382 | TENX | Tenax Therapeutics, Inc. | 749.48M | -0.47% | 360,686 | - |
| 383 | LMRI | Lumexa Imaging Holdings, Inc. | 748.70M | 0.39% | 1,861,411 | 1.02B |
| 384 | ANNX | Annexon, Inc. | 745.28M | -4.76% | 1,751,831 | - |
| 385 | BVS | Bioventus Inc. | 743.40M | -3.46% | 712,891 | 568.09M |
| 386 | SANA | Sana Biotechnology, Inc. | 739.22M | -8.58% | 2,587,141 | - |
| 387 | TLRY | Tilray Brands, Inc. | 736.32M | -3.36% | 2,053,821 | 837.32M |
| 388 | MRVI | Maravai LifeSciences Holdings, Inc. | 735.21M | -7.44% | 2,412,137 | 185.74M |
| 389 | AMN | AMN Healthcare Services, Inc. | 730.99M | -3.42% | 563,802 | 2.73B |
| 390 | IART | Integra LifeSciences Holdings Corporation | 717.02M | -1.92% | 816,485 | 1.64B |
| 391 | BIOA | BioAge Labs, Inc. | 716.73M | -0.62% | 314,109 | 9.00M |
| 392 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 710.69M | -3.79% | 143,684 | - |
| 393 | ESPR | Esperion Therapeutics, Inc. | 703.66M | -3.86% | 2,326,117 | 403.14M |
| 394 | MNKD | MannKind Corporation | 702.47M | -0.87% | 5,603,884 | 348.97M |
| 395 | OMER | Omeros Corporation | 700.50M | -4.08% | 876,911 | - |
| 396 | CSTL | Castle Biosciences, Inc. | 699.58M | -4.74% | 294,070 | 344.23M |
| 397 | SLDB | Solid Biosciences Inc. | 699.56M | -8.02% | 826,503 | - |
| 398 | LXRX | Lexicon Pharmaceuticals, Inc. | 699.07M | 1.23% | 1,713,740 | 49.80M |
| 399 | OMDA | Omada Health, Inc. | 698.56M | -10.05% | 1,204,210 | 260.21M |
| 400 | EHAB | Enhabit, Inc. | 692.88M | - | 582,620 | 1.06B |
| 401 | CMPS | COMPASS Pathways plc | 692.32M | -4.79% | 1,676,683 | - |
| 402 | DRUG | Bright Minds Biosciences Inc. | 685.13M | -4.38% | 177,863 | - |
| 403 | KURA | Kura Oncology, Inc. | 683.67M | -7.42% | 2,196,940 | 67.48M |
| 404 | RLMD | Relmada Therapeutics, Inc. | 674.44M | -1.53% | 739,613 | - |
| 405 | CBLL | CeriBell, Inc. | 668.88M | -3.32% | 292,118 | 89.06M |
| 406 | GDRX | GoodRx Holdings, Inc. | 664.59M | -4.90% | 1,566,833 | 796.85M |
| 407 | PSNL | Personalis, Inc. | 663.37M | -13.39% | 3,463,111 | 69.65M |
| 408 | PHR | Phreesia, Inc. | 661.95M | -5.75% | 1,284,055 | 463.21M |
| 409 | JBIO | Jade Biosciences, Inc. | 660.35M | -4.01% | 214,586 | - |
| 410 | ANRO | Alto Neuroscience, Inc. | 654.88M | -1.54% | 201,841 | - |
| 411 | NUTX | Nutex Health Inc. | 653.70M | -1.11% | 101,105 | 875.26M |
| 412 | DSGN | Design Therapeutics, Inc. | 649.41M | -1.59% | 184,542 | - |
| 413 | ARVN | Arvinas, Inc. | 646.01M | -7.08% | 828,478 | 262.60M |
| 414 | ETON | Eton Pharmaceuticals, Inc. | 634.09M | -0.90% | 327,288 | 79.95M |
| 415 | OCGN | Ocugen, Inc. | 631.87M | -4.59% | 6,239,410 | 4.41M |
| 416 | AVNS | Avanos Medical, Inc. | 628.78M | -2.38% | 432,838 | 701.20M |
| 417 | HSTM | HealthStream, Inc. | 619.42M | -0.71% | 212,687 | 304.06M |
| 418 | GYRE | Gyre Therapeutics, Inc. | 619.11M | -3.69% | 158,665 | 116.59M |
| 419 | MGTX | MeiraGTx Holdings plc | 618.14M | 1.20% | 566,475 | 81.39M |
| 420 | DRTS | Alpha Tau Medical Ltd. | 603.75M | -0.58% | 236,331 | - |
| 421 | LBRX | LB Pharmaceuticals Inc | 603.13M | -2.81% | 173,859 | - |
| 422 | TCMD | Tactile Systems Technology, Inc. | 599.13M | -1.66% | 246,539 | 329.52M |
| 423 | PRME | Prime Medicine, Inc. | 598.53M | -7.14% | 4,075,646 | 4.63M |
| 424 | REPL | Replimune Group, Inc. | 596.17M | -4.24% | 1,196,144 | - |
| 425 | MDXG | MiMedx Group, Inc. | 566.04M | -3.30% | 1,266,730 | 418.63M |
| 426 | ZURA | Zura Bio Limited | 562.64M | -1.82% | 703,589 | - |
| 427 | CTKB | Cytek Biosciences, Inc. | 555.34M | -5.68% | 556,788 | 201.49M |
| 428 | VALN | Valneva SE | 552.89M | -2.37% | 16,978 | 205.07M |
| 429 | TECX | Tectonic Therapeutic, Inc. | 551.09M | -4.58% | 157,655 | - |
| 430 | ALLO | Allogene Therapeutics, Inc. | 550.94M | -6.22% | 6,330,340 | 22.00K |
| 431 | YDES | YD Bio Limited | 549.20M | 3.23% | 1,789 | 510.36K |
| 432 | SIBN | SI-BONE, Inc. | 542.79M | -4.28% | 490,029 | 200.93M |
| 433 | ZVRA | Zevra Therapeutics, Inc. | 537.80M | -2.55% | 519,787 | 106.47M |
| 434 | CRMD | CorMedix Inc. | 530.43M | 0.15% | 1,512,969 | 311.71M |
| 435 | EIKN | Eikon Therapeutics, Inc. | 529.59M | -6.84% | 201,458 | - |
| 436 | AVR | Anteris Technologies Global Corp. | 529.00M | -3.71% | 1,097,545 | 1.91M |
| 437 | AGMB | AgomAb Therapeutics NV | 528.79M | -8.59% | 67,751 | - |
| 438 | EMBC | Embecta Corp. | 507.51M | -3.38% | 818,761 | 1.08B |
| 439 | MCTA | Charming Medical Limited | 504.26M | -0.85% | - | 6.22M |
| 440 | CBIO | Crescent Biopharma, Inc. | 503.52M | 12.30% | 428,494 | 10.84M |
| 441 | IRWD | Ironwood Pharmaceuticals, Inc. | 498.96M | -2.86% | 1,350,675 | 296.15M |
| 442 | PRTA | Prothena Corporation plc | 498.49M | -2.73% | 430,062 | 9.68M |
| 443 | CTNM | Contineum Therapeutics, Inc. | 498.06M | -2.27% | 168,819 | - |
| 444 | AQST | Aquestive Therapeutics, Inc. | 490.62M | -2.90% | 1,198,422 | 44.55M |
| 445 | ACRS | Aclaris Therapeutics, Inc. | 489.26M | - | 2,387,967 | 7.83M |
| 446 | FLGT | Fulgent Genetics, Inc. | 486.89M | -4.76% | 599,129 | 322.67M |
| 447 | PROK | ProKidney Corp. | 483.07M | -9.60% | 1,509,307 | 893.00K |
| 448 | LRMR | Larimar Therapeutics, Inc. | 479.94M | -4.74% | 1,044,709 | - |
| 449 | BBNX | Beta Bionics, Inc. | 477.55M | -6.60% | 812,652 | 100.25M |
| 450 | RIGL | Rigel Pharmaceuticals, Inc. | 476.79M | -2.01% | 269,240 | 294.28M |
| 451 | FDMT | 4D Molecular Therapeutics, Inc. | 476.31M | -8.35% | 1,059,686 | 85.21M |
| 452 | UPB | Upstream Bio, Inc. | 471.82M | -11.44% | 939,762 | 2.85M |
| 453 | KYTX | Kyverna Therapeutics, Inc. | 471.04M | -2.86% | 688,353 | - |
| 454 | ADCT | ADC Therapeutics SA | 470.06M | -6.57% | 1,005,361 | 81.36M |
| 455 | CATX | Perspective Therapeutics, Inc. | 463.71M | -3.55% | 911,233 | 884.00K |
| 456 | KMDA | Kamada Ltd. | 462.65M | -0.85% | 185,390 | 180.46M |
| 457 | OFIX | Orthofix Medical Inc. | 461.66M | -2.46% | 239,888 | 822.31M |
| 458 | LYEL | Lyell Immunopharma, Inc. | 458.45M | -2.72% | 38,709 | 36.00K |
| 459 | FBRX | Forte Biosciences, Inc. | 454.70M | -5.59% | 283,031 | - |
| 460 | VREX | Varex Imaging Corporation | 449.80M | -0.46% | 296,801 | 854.40M |
| 461 | ANGO | AngioDynamics, Inc. | 449.27M | -3.28% | 474,259 | 307.31M |
| 462 | NPCE | NeuroPace, Inc. | 448.78M | -2.34% | 249,644 | 99.99M |
| 463 | FULC | Fulcrum Therapeutics, Inc. | 448.22M | -3.03% | 390,887 | 80.00M |
| 464 | VSTM | Verastem, Inc. | 442.69M | -4.73% | 1,653,203 | 30.91M |
| 465 | NAUT | Nautilus Biotechnology, Inc. | 440.44M | -7.94% | 431,436 | - |
| 466 | ASMB | Assembly Biosciences, Inc. | 439.40M | -4.05% | 70,466 | 72.30M |
| 467 | IMMX | Immix Biopharma, Inc. | 431.66M | -6.54% | 750,482 | - |
| 468 | STTK | Shattuck Labs, Inc. | 430.82M | -4.60% | 526,424 | 1.00M |
| 469 | TRDA | Entrada Therapeutics, Inc. | 429.48M | -3.09% | 126,796 | 25.42M |
| 470 | ENGN | enGene Holdings Inc. | 426.72M | -8.48% | 162,375 | - |
| 471 | ABSI | Absci Corporation | 425.40M | -3.47% | 4,206,305 | 2.80M |
| 472 | AUNA | Auna S.A. | 418.17M | -2.42% | 231,722 | 1.30B |
| 473 | EPRX | Eupraxia Pharmaceuticals Inc. | 412.76M | -1.90% | 82,141 | - |
| 474 | EBS | Emergent BioSolutions Inc. | 409.54M | -1.86% | 639,722 | 742.90M |
| 475 | RCKT | Rocket Pharmaceuticals, Inc. | 409.31M | -19.62% | 23,207,222 | - |
| 476 | VNDA | Vanda Pharmaceuticals Inc. | 408.44M | -2.95% | 1,234,926 | 216.11M |
| 477 | AVIR | Atea Pharmaceuticals, Inc. | 407.92M | -3.94% | 320,120 | - |
| 478 | STRO | Sutro Biopharma, Inc. | 404.74M | -1.08% | 91,840 | 102.48M |
| 479 | RGNX | REGENXBIO Inc. | 400.52M | -6.05% | 630,783 | 170.44M |
| 480 | MYGN | Myriad Genetics, Inc. | 400.21M | -7.36% | 1,617,883 | 824.50M |
| 481 | LXEO | Lexeo Therapeutics, Inc. | 398.51M | -3.36% | 881,161 | - |
| 482 | AURA | Aura Biosciences, Inc. | 398.17M | -2.64% | 275,914 | - |
| 483 | NMRA | Neumora Therapeutics, Inc. | 395.96M | -6.43% | 953,402 | - |
| 484 | ALT | Altimmune, Inc. | 392.92M | -5.63% | 2,674,890 | 41.00K |
| 485 | KIDS | OrthoPediatrics Corp. | 392.33M | -5.08% | 138,277 | 236.35M |
| 486 | NRC | National Research Corporation | 389.65M | -1.32% | 47,410 | 137.39M |
| 487 | IVVD | Invivyd, Inc. | 387.15M | -9.27% | 2,577,626 | 53.43M |
| 488 | CYH | Community Health Systems, Inc. | 382.85M | -2.39% | 1,394,533 | 12.49B |
| 489 | PACB | Pacific Biosciences of California, Inc. | 380.52M | -6.67% | 8,686,011 | 160.01M |
| 490 | SIGA | SIGA Technologies, Inc. | 379.72M | 6.85% | 1,341,562 | 94.57M |
| 491 | CV | CapsoVision, Inc. | 374.28M | -0.27% | 288,209 | 13.55M |
| 492 | LCTX | Lineage Cell Therapeutics, Inc. | 371.14M | -2.61% | 1,006,922 | 14.56M |
| 493 | PLYX | Polaryx Therapeutics, Inc. | 368.80M | 22.10% | 2,616,627 | - |
| 494 | XFOR | X4 Pharmaceuticals, Inc. | 367.32M | -6.26% | 320,161 | 35.11M |
| 495 | DMAC | DiaMedica Therapeutics Inc. | 363.80M | -0.88% | 180,929 | - |
| 496 | IPSC | Century Therapeutics, Inc. | 363.04M | -1.94% | 1,549,879 | 109.16M |
| 497 | MNPR | Monopar Therapeutics Inc. | 361.53M | -0.48% | 184,310 | - |
| 498 | SRTA | Strata Critical Medical, Inc. | 360.14M | -2.59% | 527,736 | 197.14M |
| 499 | XOMA | XOMA Royalty Corporation | 359.19M | -1.18% | 99,985 | 52.15M |
| 500 | AKBA | Akebia Therapeutics, Inc. | 358.96M | -3.60% | 2,634,987 | 236.20M |